Media > INOVIQ in the News

INOVIQ in the News

INOVIQ in the News

8-Feb-2023	Sectors mixed as ASX edges 0.35% higher

8-Feb-2023	Stocks of the Hour: Tennant Minerals, Latin Resources, INOVIQ

21-Dec-2022	Passing of Professor Allan Cripps AO

15-Dec-2022	INOVIQ presents at the MST Access Diagnostics Forum

13-Dec-2022	Stocks of the Hour: Kingwest Resources, Doctor Care Anywhere, INOVIQ

28-Nov-2022	China's lockdown rampage causes lower start to ASX

25-Nov-2022	Lithium stocks falling, Critical Minerals Summit commencing: ASX up 0.29% at noon

16-Nov-2022	The Australian: Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US

13-Oct-2022	The Market Herald: INOVIQ signs agreement with Nicoya Lifesciences to develop SubB2M-based test

13-Oct-2022	Financials keeping the local market in the green: ASX up 0.51% at noon

27-Sep-2022	Stockhead Health & Biotech Investment Guide

8-Sep-2022	INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market

29-Jul-2022	INOVIQ (ASX:IIQ) discusses US milestones

26-Jul-2022	INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma

26-Jul-2022	Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher

26-Jul-2022	ASX in a holding pattern: Aus shares 0.2% higher at noon

22-Jul-2022	INOVIQ expands US footprint with new sales team

1-Jul-2022	Energy and miners drag ASX lower, down 0.6% over the week

1-Jul-2022	INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications

22-Apr-2022	Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test

5-Apr-2022	INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions

21-Dec-2021	Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests

4-Nov-2021	BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021

15-Feb-2021	INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.

14-Feb-2021	INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.

3-Dec-2020	Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.

3-Sep-2020	AusBiotech: Government announces support for COVID-19 research projects

10-Aug-2020	INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests

24-Apr-2020	INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.

23-Oct-2018	Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer

23-Oct-2018	Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection

21-May-2018	Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies

21-May-2018	Article published by finfeed INOVIQ inks critical deal to develop autoantibody test

18-May-2018	Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation

18-May-2018	Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay

10-Jan-2018	INOVIQ announces positive results from ovarian cancer test

9-Jan-2018	Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study

2-Jan-2017	Interview of INOVIQ LSL Executive Director and CSO Dr Irmgard Irminger-Finger by Startwerk “BARD1AG SA: The real fight against lung cancer”